{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:40:34Z","timestamp":1792536034520,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13969-1","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:07:30Z","timestamp":1784801250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance patterns and difficult-to-treat resistance in uropathogens among diabetic and non-diabetic patients: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3289-4761","authenticated-orcid":false,"given":"Ankita","family":"Priyadarshini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3317-2460","authenticated-orcid":false,"given":"Priyal","family":"Kalola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-9963","authenticated-orcid":false,"given":"Hemantkumar","family":"Patadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"4","key":"13969_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0924-8579(01)00303-X","volume":"17","author":"AR Ronald","year":"2001","unstructured":"Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: Research priorities and strategies. Int J Antimicrob Agents. 2001;17(4):343\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"13969_CR2","first-page":"445","volume":"28","author":"P Behzadi","year":"2008","unstructured":"Behzadi P, Behzadi E. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turkiye Klin J Med Sci. 2008;28(4):445\u20139.","journal-title":"Turkiye Klin J Med Sci"},{"issue":"1","key":"13969_CR3","first-page":"1","volume":"14","author":"HZ Hamdan","year":"2015","unstructured":"Hamdan HZ, Kubbara E, Adam AM, Hassan OS, Suliman SO, Adam I. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob [Internet]. 2015;14(1):1\u20136. Available from: ???.","journal-title":"Ann Clin Microbiol Antimicrob [Internet]"},{"key":"13969_CR4","unstructured":"Kumar Jha P, Baral R, Khanal B. Prevalence of uropathogens in diabetic patients and their susceptibility pattern at a tertiary care center in Nepal: a retrospective study. Int J Biomed Lab Sci. 2014;(2):29."},{"issue":"9","key":"13969_CR5","first-page":"10","volume":"12","author":"S Ramrakhia","year":"2020","unstructured":"Ramrakhia S, Raja K, Dev K, Kumar A, Kumar V, Kumar B. Comparison of Incidence of Urinary Tract Infection in Diabetic vs Non-Diabetic and Associated Pathogens. Cureus. 2020;12(9):10\u20134.","journal-title":"Cureus"},{"issue":"2","key":"13969_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cpha.2016.12.003","volume":"2","author":"T Solh","year":"2017","unstructured":"Solh T, Thomas R, Roman C. Current Diagnosis and Management of Urinary Tract Infections. Physician Assist Clin. 2017;2(2):191\u2013205.","journal-title":"Physician Assist Clin"},{"issue":"1","key":"13969_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3997-0","volume":"19","author":"R Ganesh","year":"2019","unstructured":"Ganesh R, Shrestha D, Bhattachan B, Rai G. Epidemiology of urinary tract infection and antimicrobial resistance in a pediatric hospital in Nepal. BMC Infect Dis. 2019;19(1):1\u20135.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"13969_CR8","first-page":"359","volume":"13","author":"A Al-Badr","year":"2013","unstructured":"Al-Badr A, Al-Shaikh G. Recurrent Urinary Tract Infections Management in Women A review. Sultan Qaboos Univ Med J. 2013;13(3):359\u201367.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"13969_CR9","doi-asserted-by":"publisher","unstructured":"Alghoraibi H, Asidan A, Aljawaied R, Almukhayzim R, Alsaydan A, Alamer E, et al. Recurrent urinary tract infection in adult patients, risk factors, and efficacy of low-dose prophylactic antibiotics therapy. J Epidemiol Glob Health [Internet]. 2023;13(2):200\u201311. Available from: https:\/\/doi.org\/10.1007\/s44197-023-00105-4.","DOI":"10.1007\/s44197-023-00105-4"},{"key":"13969_CR10","doi-asserted-by":"publisher","unstructured":"Kamei J, Yamamoto S. Complicated urinary tract infections with diabetes mellitus. J Infect Chemother [Internet]. 2021;27(8):1131\u20136. Available from: https:\/\/doi.org\/10.1016\/j.jiac.2021.05.012.","DOI":"10.1016\/j.jiac.2021.05.012"},{"issue":"5","key":"13969_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):103\u201320.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"13969_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"SS Kadri","year":"2018","unstructured":"Kadri SS, Adjemian J, Lai L, Spaulding AB, Ricotta E, Prevots DR, et al. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin Infect Dis. 2018;67(12):1803\u201314.","journal-title":"Clin Infect Dis"},{"key":"13969_CR13","doi-asserted-by":"crossref","unstructured":"Cosentino F, Viale P, Giannella M, O PINION MDR \/. XDR \/ PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? 2024;36(6):564\u201371.","DOI":"10.1097\/QCO.0000000000000966"},{"issue":"1","key":"13969_CR14","first-page":"1","volume":"13","author":"U Ravishankar","year":"2021","unstructured":"Ravishankar U, Sathyamurthy P, Thayanidhi P. Antimicrobial Resistance Among Uropathogens: Surveillance Report From South India. Cureus. 2021;13(1):1\u201312.","journal-title":"Cureus"},{"issue":"January","key":"13969_CR15","first-page":"1","volume":"5","author":"A Shinde","year":"2026","unstructured":"Shinde A, Mohan A, Bulusu VM. Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine. Front Antibiot. 2026;5(January):1\u201316.","journal-title":"Front Antibiot"},{"issue":"January","key":"13969_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Classification and Diagnosis of Diabetes: Standards ofCare in Diabetes\u20142023. Diabetes Care. 2023;46(January):19\u201340.","journal-title":"Diabetes Care"},{"issue":"1","key":"13969_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5152\/tud.2018.32855","volume":"45","author":"M Mama","year":"2019","unstructured":"Mama M, Manilal A, Gezmu T, Kidanewold A, Gosa F, Gebresilasie A. Prevalence and associated factors of urinary tract infections among diabetic patients in arba minch hospital, Arba Minch province, South Ethiopia. Turkish J Urol. 2019;45(1):56\u201362.","journal-title":"Turkish J Urol"},{"key":"13969_CR18","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne (PA): CLSI; 2023."},{"issue":"1","key":"13969_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00042307-200101000-00007","volume":"11","author":"MJ Bono","year":"2001","unstructured":"Bono MJ, Leslie SW, Reygaert WC. Uncomplicated urinary tract infections. Curr Opin Urol. 2001;11(1):49\u201353.","journal-title":"Curr Opin Urol"},{"issue":"30","key":"13969_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2022.27.30.2101012","volume":"27","author":"J Salm","year":"2022","unstructured":"Salm J, Salm F, Arendarski P, Kramer TS. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Eurosurveillance. 2022;27(30):1\u201311.","journal-title":"Eurosurveillance"},{"issue":"3","key":"13969_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12691\/ajmr-9-3-3","volume":"9","author":"E Chito Clare","year":"2021","unstructured":"Chito Clare E, Oluchi Juliet A, Chioma Maureen O, James Romeo A, Evelyn Ada KO. Urinary Tract Infections and Antimicrobial Sensitivity Patterns of Uropathogens Isolated from Diabetic and Non-diabetic Patients Attending Some Hospitals in Awka. Am J Microbiol Res. 2021;9(3):83\u201391.","journal-title":"Am J Microbiol Res"},{"issue":"3","key":"13969_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00345-012-0934-x","volume":"31","author":"KA Al-Rubeaan","year":"2013","unstructured":"Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MRM. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013;31(3):573\u20138.","journal-title":"World J Urol"},{"issue":"1","key":"13969_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/1118-8561.232779","volume":"21","author":"T Oluwafemi","year":"2018","unstructured":"Oluwafemi T, Akinbodewa A, Ogunleye A, Adejumo O. Urinary tract infections and antibiotic sensitivity pattern of uropathogens in a tertiary hospital in South West, Nigeria. Sahel Med J. 2018;21(1):18.","journal-title":"Sahel Med J"},{"key":"13969_CR24","first-page":"129","volume":"8","author":"O Nitzan","year":"2015","unstructured":"Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: Review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129\u201336.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"13969_CR25","unstructured":"Ng M, Leslie SW, Baradhi KM. Benign prostatic hyperplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026;1\u201329."},{"issue":"4","key":"13969_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/diseases10040124","volume":"10","author":"E Owusu","year":"2022","unstructured":"Owusu E, Adjei H, Afutu E. Similarities in Bacterial Uropathogens and Their Antimicrobial Susceptibility Profile in Diabetics and Their Non-Diabetic Caregivers at a National Diabetes Management and Research Centre, Accra-Ghana. Diseases. 2022;10(4):124.","journal-title":"Diseases"},{"issue":"1","key":"13969_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2911-x","volume":"18","author":"WD Seifu","year":"2018","unstructured":"Seifu WD, Gebissa AD. Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia. BMC Infect Dis. 2018;18(1):1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"13969_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4103\/1110-2098.163918","volume":"28","author":"M Gab-Allah El-Nagar","year":"2015","unstructured":"Gab-Allah El-Nagar M, Dawood AEDES, Gabr H, Abd El-Naby EED. Prevalence of urinary tract infection in Damietta diabetic patients. Menoufia Med J. 2015;28(2):559.","journal-title":"Menoufia Med J"},{"key":"13969_CR29","doi-asserted-by":"crossref","unstructured":"Akinnibosun F. Prevalence of uropathogens in diabetic patients and their antimicrobial susceptibility pattern. Niger Soc Microbiol J [Internet]. 2009;12(2):3235\u201341. Available from: http:\/\/nsmjournal.org.ng\/2016-30-1\/09.pdf.","DOI":"10.67614\/njm.2016.2yz0tbea"},{"key":"13969_CR30","doi-asserted-by":"crossref","unstructured":"Aje Anejo-Okopi J, Julius Okojokwu O, Ramyil SMC, Barnabas Bakwet P, Okechalu J, Agada G, et al. Bacterial and antibiotic susceptibility pattern of urinary tract infection isolated from asymptomatic and symptomatic diabetic patients attending tertiary hospital in Jos, Nigeria. Trends Med. 2017;17(1).","DOI":"10.15761\/TiM.1000108"},{"issue":"3","key":"13969_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2796.2003.01197.x","volume":"254","author":"JP Horcajada","year":"2003","unstructured":"Horcajada JP, Moreno I, Velasco M, Mart\u00ednez JA, Moreno-Mart\u00ednez A, Barranco M, et al. Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med. 2003;254(3):280\u20136.","journal-title":"J Intern Med"},{"issue":"2","key":"13969_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/acmi.0.000321","volume":"4","author":"S Mohapatra","year":"2022","unstructured":"Mohapatra S, Panigrahy R, Tak V, S JV, Chaudhuri KCS. Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 2022;4(2):1\u20139.","journal-title":"Access Microbiol"},{"key":"13969_CR33","doi-asserted-by":"crossref","unstructured":"Mares C, Petca RC, Popescu RI, Petca A, Multescu R, Bulai CA, et al. Update on urinary tract infection antibiotic resistance: a retrospective study in females in conjunction with clinical data. Life (Basel). 2024;14(106).","DOI":"10.3390\/life14010106"},{"key":"13969_CR34","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net): Annual epidemiological report 2023. ECDC. 2024 Nov."},{"issue":"10","key":"13969_CR35","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791\u20138.","journal-title":"Emerg Infect Dis"},{"key":"13969_CR36","unstructured":"Kyungmin Huh, Chung DR, Ha YE, Ko JH, Kim SH, Kim MJ, et al. Impact of difficult-to-treat resistance in gram-negative bacteremia on mortality: retrospective analysis of nationwide surveillance data. Oxferd Univ. 2020;1\u201323."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13969-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:27:03Z","timestamp":1792535223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13969-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13969"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13969-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The research protocol was approved by Parul University Institutional Ethics Committee for Human Research (PU-IECHR) with the approval number: PUIECHR\/PIMSR\/00\/081734\/4006 and informed consent was obtained. The study was carried out with strict adherence to confidentiality and privacy protocols throughout the research process. No personal identifiers or patient names were recorded in the data collection sheets; instead, each participant was assigned a unique identification number to maintain anonymity and confidentiality. All data were anonymized prior to analysis and handled in accordance with institutional data privacy guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1839"}}